Majid Ebrahimi Warkiani

"Cancer is one of the world’s deadliest human diseases. While considerable progress has been made in the decades-long war on cancer, there is an unmet clinical need for new solutions for cancer management. In his pitch, Majid will describe his team’s efforts in development of a new system for isolation of circulating tumour cells (CTCs) from blood of patients with cancer for early cancer diagnosis. Additionally, he will present their recent efforts for building the first tumour filtering system (CTC-pheresis) which can be employed for filtration of whole blood as a therapy to remove CTCs, and maintain the absolute number of CTCs for a given cancer type within the “safe zone”, thus increasing the overall survival of metastatic patients."